- 103.1k views
Orthopedic Conditions In Aging Population
As people age, their musculoskeletal system undergoes changes that can lead to various orthopedic conditions. Bones lose density, which can result in osteoporosis and bone fractures. Muscle weakness associated with aging can also occur. Osteoarthritis is a common condition that can cause pain and stiffness in the joints, especially in the morning or after overuse of the joint. The cartilage in the joints can wear out over time, leading to bones rubbing painfully against each other. Other common musculoskeletal conditions include back pain, arthritis, and broken bones. To keep the musculoskeletal system healthy, it is important to maintain a healthy weight, exercise regularly, and eat a balanced diet.
About the Speaker

Dr Rajesh Dharia
Dr. Rajesh Dharia has a reputation to solve all unsolved bone and joint problems. We have failed surgical cases being refered to us from all over india and abroad. We believe in maintaining professional relationships. Dr. Dharia strongly advocates that primary surgery should be done in a place that can offer the best to the patient in terms of services offered by the treating surgeon. Dr. Rajesh Dharia is trained in Mumbai, UK, Germany, USA , Japan and Australia.
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.